Latest news & insights
UK rejoins EU Horizon scheme: Professor Alan Boyd comments
The government has announced that the UK is to re-join the EU’s flagship scientific research scheme, Horizon. UK-based scientists and institutions will be able to apply for money from the £81bn (€95bn) fund from today. Associate membership had been agreed as part of the Brexit trade deal when the UK formally left the EU in 2020.
Webinar: How to successfully operationalize real-world data collection alongside expanded access programs
On 05 October, Boyds will be co-hosting a live webinar with Cisiv, discussing how to successfully operationalize real-world data collection alongside expanded access programs.
Boyds strengthens team with regulatory operations and publishing expertise
Boyds is pleased to announce the appointment of regulatory operations and publishing professional Michelle Hackney to lead our new in-house Regulatory Operations offering.
Boyds launches Regulatory Operations service
Boyds are excited to announce the expansion of its service offering with the launch of a new in-house regulatory operations service that will enable the company to support the full lifecycle of its clients’ drug development projects.
Karen Mullen recognised as a Global Fellow in Medicines Development
We are delighted to congratulate Chief Medical Officer at Boyds, Dr Karen Mullen, on being recognised as a Global Fellow in Medicines Development (GFMD) by the Academy of Global Medicines Development Professionals.
Boyds expands regulatory affairs team in the US
Boyds is delighted to announce the appointment of regulatory affairs professional Eric Hardter to our US team.
